CADL
Price
$4.53
Change
-$0.42 (-8.48%)
Updated
Apr 16 closing price
Capitalization
213.98M
21 days until earnings call
INKT
Price
$7.83
Change
+$0.08 (+1.03%)
Updated
Apr 16 closing price
Capitalization
30.74M
20 days until earnings call
Ad is loading...

CADL vs INKT

Header iconCADL vs INKT Comparison
Open Charts CADL vs INKTBanner chart's image
Candel Therapeutics
Price$4.53
Change-$0.42 (-8.48%)
Volume$616.18K
Capitalization213.98M
MiNK Therapeutics
Price$7.83
Change+$0.08 (+1.03%)
Volume$2.81K
Capitalization30.74M
CADL vs INKT Comparison Chart
Loading...
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CADL vs. INKT commentary
Apr 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and INKT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 17, 2025
Stock price -- (CADL: $4.53 vs. INKT: $7.83)
Brand notoriety: CADL and INKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 53% vs. INKT: 29%
Market capitalization -- CADL: $213.98M vs. INKT: $30.74M
CADL [@Biotechnology] is valued at $213.98M. INKT’s [@Biotechnology] market capitalization is $30.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $287.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileINKT’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • INKT’s FA Score: 0 green, 5 red.
According to our system of comparison, INKT is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while INKT’s TA Score has 3 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 6 bearish.
  • INKT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CADL and INKT are a bad buy in the short-term.

Price Growth

CADL (@Biotechnology) experienced а -11.09% price change this week, while INKT (@Biotechnology) price change was +3.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.47%. For the same industry, the average monthly price growth was -15.91%, and the average quarterly price growth was -25.65%.

Reported Earning Dates

CADL is expected to report earnings on Sep 03, 2025.

INKT is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+2.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($214M) has a higher market cap than INKT($30.7M). INKT YTD gains are higher at: 12.355 vs. CADL (-47.811). INKT has higher annual earnings (EBITDA): -14.07M vs. CADL (-48.83M). CADL has more cash in the bank: 16.6M vs. INKT (393K). INKT has less debt than CADL: INKT (4.61M) vs CADL (16M). CADL (0) and INKT (0) have equivalent revenues.
CADLINKTCADL / INKT
Capitalization214M30.7M697%
EBITDA-48.83M-14.07M347%
Gain YTD-47.81112.355-387%
P/E RatioN/AN/A-
Revenue00-
Total Cash16.6M393K4,224%
Total Debt16M4.61M347%
TECHNICAL ANALYSIS
Technical Analysis
CADLINKT
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNPIX39.57N/A
N/A
ProFunds Financials UltraSector Inv
AWEIX28.98N/A
N/A
CIBC Atlas Disciplined Equity Instl
SBSDX42.23N/A
N/A
Franklin S&P 500 Index D
TVOAX33.33N/A
N/A
Touchstone Small Cap Value A
SHSKX65.92N/A
N/A
BlackRock Health Sciences Opps K

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with CYYNF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-8.48%
CYYNF - CADL
46%
Loosely correlated
N/A
RPTX - CADL
39%
Loosely correlated
+4.55%
MDGL - CADL
33%
Poorly correlated
-4.15%
PRTA - CADL
32%
Poorly correlated
-3.44%
INO - CADL
32%
Poorly correlated
-2.27%
More

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with LPTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then LPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
+1.03%
LPTX - INKT
43%
Loosely correlated
-1.42%
RAIN - INKT
43%
Loosely correlated
+6.64%
ABCZF - INKT
33%
Loosely correlated
N/A
SABS - INKT
31%
Poorly correlated
+0.72%
TERN - INKT
30%
Poorly correlated
-6.67%
More